Engineers Gate Manager LP Spectrum Pharmaceuticals Inc Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.43 - $1.56 $14,885 - $54,002	-34,617 Reduced 55.0%	28,324 $12,000
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $13,361 - $33,720	-21,208 Reduced 25.2%	62,941 $81,000
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.42 $106,869 - $203,640	84,149 New	84,149 $107,000
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $32,025 - $60,375	-17,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $61,250 - $181,125	17,500 New	17,500 $64,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.